Abstract
Modern endoscopic techniques are being practised by a progressively wider spectrum of specialists for a greater range of both diagnostic and increasingly complex therapeutic procedures, particularly in the fields of gastroenterology, urology [1], gynaecology and cardiology, by orthopaedic and vascular surgeons, and interventional radiologists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Birch BRP, Anson KM, Miller RA (1990) Sedoanalgesia in urology: a safe, cost- effective alternative to general anaesthesia. A review of 1020 cases. Br J Urol 66: 342–350
Department of Health Standing Dental Advisory Commitee (1991) Report of an expert working party. General anaesthesia, sedation and resuscitation in dentistry (In press)
Cockshott ID (1985) Propofol (Diprivan). Pharmacokinetics and metabolism — an overview. Postgrad Med J 61 (Suppl 3): 45–50
Mackenzie N, Grant IS (1987) Propofol for intravenous sedation. Anaesthesia 42: 3–6
Roberts FL, Dixon J, Lewis GTR, Tackley RM, Prys-Roberts C (198S) Induction and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia 43 (Suppl): 14–17
Rudkin GE, Osborne GA, Curtis NJ (1991) Intra-operative patient-controlled sedation. Anaesthesia 46: 90–92
Thompson GE, Moore DC (1971) Ketamine, Diazepam and Innovar. A computerised comparative study. Anesth Analg 50: 458–463
Podiesch I, Dähn H, Engel M (1985) Anaesthetic and side effects of midazolam and ketamine in surgical patients. Anesthesiology 62: 68
Seitz W, Lübbe N, Hamkens A, Bornscheuer A (1988) Midazolam-Ketamin- Kombinationsanaesthesie bei traumatologischen Eingriffen. Anaesthetist 37:231– 237
Thomson D (ed) (1990) Midazolam and Flumazenil — the agonist-antagonist concept for sedation and anaesthesia. Proceedings of an international symposium, April 1989. Acta Anaesthesiol Scand 34 (Suppl 92) 1–109
Möhler H, Okada T (1977) Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849–851
Braestrup C, Squires RF (1977) Specific benzodiazepine receptors in rat brain characterised by high-affinity 3H-diazepam binding. Proceedings of the National Academy of Sciences USA 74: 3805–3809
Richards JG, Möhler H (1984) Benzodiazepine receptors. Neuropharmacology 23: 233–242
Braestrup C, Nielsen M (1982) Neurotransmitters and CNS disease; anxiety. Lancet 2: 1030–1034
Chang LR, Barnard EA (1982) The benzodiazepine/GABA receptor complex: molecular size in brain synaptic membranes and in solution. J Neurochem 39:1507– 1518
Schoch P, Richards JG, Häring P, Takacs B, Stähli C, Staehelin T, Haefely W, Möhler H (1985) Co-localisation of GABA and benzodiazepine receptors in the brain. Nature 314: 168–170
Möhler H, Schoch P, Richards JG, Häring P, Takacs B, Stähli C (1986) Monoclonal antibodies: probes for structure and location of the GABA receptor/benzodiazepine receptor/chloride channel complex. In: Benzodiazepine-GABA receptors and chloride channels: structural and functional properties. Olsen RW, Venter JC (eds). New York: Alan R Liss, Inc.
Schofield PR, Darlinson MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA, Seeburg PH, Barnard EA (1987) Sequence and functional expression of the GABA receptor shows a ligand- gated receptor super-family. Nature 328: 221–227
Erdö S (1985) Peripheral GABA ergic mechanisms. Trends in Pharmacological Sciences 6: 205–208
Mestre M, Carriot T, Belin C, Uzan A, Renault C, Dubroeqcq MC, Gueremy C, Le Fur G (1985) Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sei 35:953– 962
Braestrup C, Nielsen M, Olsen CE (1980) Urinary and brain ß-carboline-3-carboxyla- tes as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sei USA 77: 2288–2292
Braestrup C, Nielsen M (1981) GABA reduced binding 3H-methyl ß-carboline-car- boxylate to brain benzodiazepine receptors. Nature 294: 472–475
Braestrup C, Schiechen R, Neef G, Nielsen M, Petersen EN (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216: 1241–1243
Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E (1983) Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonist action on benzodiazepine receptors. Proc Natl Acad Sei USA 80: 3531–3535
Editorial (1987) Diazepam binding inhibitor. Lancet 1: 307–308
Ferrero P, Sahti MR, Conti-Tronconi B, Costa E, Guidotti A (1985) Study of an octadecaneuropeptide derived diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sei USA 83: 827–831
Marquardt H, Todaro GJ, Shoyab M (1986) Complete amino acid sequences of bovine and human endozepines. J Biol Chem 261: 9727–9731
Ferrero P, Guidotti A, Conti-Troncon B, Costa E (1984) A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology 23: 1359–1362
Little HJ, Nutt DJ, Taylor SC (1987) Kindling and withdrawal changes at the benzodiazepine receptor. Journal of Psychopharmacology 1: 35–46
Richards JG, Schoch PO, Möhler H, Haefely W (1986) Benzodiazepine receptors resolved. Experientia 42: 121–126
Darragh A, Lambe R, Kenny M, Brick I, O’Boyle C, Taffe W (1982) Rol5-1788 antagonises the central diazepam in man without altering diazepam availability. Br J Clin Pharmacol 14: 677–682
O’Boyle C, Lambe R, Darragh A, Taffe W, Brick I, Kenny M (1983) Rol5-1788 antagonises the effects of diazepam in man without affecting its bioavailability. Br J Anaesth 55: 349–355
Amrein R, Hetzel W (1990) Pharmacology of Dormicum (midazolam) and Anexate (Flumazenil). Acta Anaesthesiol Scand (Suppl 92 ) 34: 6 - 15
Crevoisier C, Ziegler WH, Heizmann P, Dubuis R (1984) Relation entre l’effet clinique et la concentration plasmatique du midazolam chez des sujets volontaires. Ann Fr Anesth Reanim 3: 162–167
Persson MP, Nilsson A, Hartvig P (1988) Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 43:324– 331
Lauven PM, Stoeckel H (1987) Hypnotische wirksame Blutspiegel von Midazolam. Anasth Intensivther Notfallmed 22: 90–93
Raeder JC, Nilsen G, Hole A (1988) Pharmacokinetics of midazolam and alfentanil in outpatient general anaesthesia. Acta Anaesthesiol Scand 32: 467–472
Lauven PM, Schwilden H, Stoeckel H, Greenblatt DJ (1985) The effects of a benzodiazepine antagonist Ro15-1788 in the presence of stable concentrations of midazolam. Anesthesiology 63: 61–64
Riou B, Rimailho A, Galliot M, Bourdon R, Huet Y (1988) Protective cardiovascular effects of diazepam in chloroquine poisoning. Intensive Care Med 14: 610–616
Sanders LD, Davies-Evans J, Rosen M, Robinson JO (1989) Comparison of diazepam with midazolam as i.v. sedation for outpatient gastroscopy. Br J Anaesth 63: 726–731
Whitwam JG, Al-Khudhairi D, McCloy RF (1983) Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy. Br J Anaesth 55: 773–777
Gamble JAS, Kawar P, Dundee JW, Moore J, Briggs LP (1981) Evaluation of midazolam as an intravenous induction agent. Anaesthesia 36: 868–873
Bell GD, Antrobus JHL, Lee J, Coady T, Morden A (1990) Bolus or slow titrated injection of midazolam prior to upper gastrointestinal endoscopy? Relative effect on oxygen saturation and prophylactic value of supplemental oxygen. Alimentary Pharmacology and Therapeutics 4: 393–401
Swain DG, Ellis DJ, Bradby H (1990) Rapid intravenous low-dose diazepam as sedation for upper gastrointestinal endoscopy. Alimentary Pharmacology and Therapeutics 4: 43–48
Dundee JW, Collier PS, Carlisle RJT, Harper KW (1986) Prolonged midazolam elimination half-life. Br J Clin Pharmacol 21: 425–429
Kassai A, Toth G, Eichelbaum M, Klotz U (1988) No evidence of a genetic polymorphism in the oxidative metabolism of midazolam. Clin Pharmacokinet 15:319– 325
Adams P, Gelman S, Reves JG, Alvis M, Greenblatt DT et al (1985) Midazolam pharmacokinetics and pharmacodynamics during acute hypovolemia. Anesthesiology 63: 140–146
Shelly MP, Mendel L, Park GR (1987) Failure of critically ill patients to metabolise midazolam. Anaesthesia 42: 619–626
Kalow W (1982) Ethnic differences in drug metabolism. Clin Pharmacokinet 7: 373–400
Cook PJ, Bennett PN, Lennard-Jones JE, Warnes TW (1978) Premedication for endoscopy. Scand J Gastroenterol 13: 33–39
Swenzen GO, Chakrabarti MK, Sapsed-Byrne S, Whitwam JG (1988) Selective depression by alfentanil of Group III and IV somatosympathetic reflexes in the dog. Br J Anaesth 61: 441–445
Whitwam JG (1988) Summary of meeting. In:Kallar SK, Whitwam JG (eds). Outpatient anaesthesia. Proceedings of an international symposium, Antwerp, Belgium, 9th June 1988 Amsterdam: Medicom
Ben-Shlomo I, Abd-El-Khalim H, Ezry J, Zohar S, Tverskoy M (1990) Midazolam acts synergistically with fentanyl for induction of anaesthesia. Br J Anaesth 64: 45–47
Vinik HR, Bradley EL, Kissin I (1989) Midazolam-alfentanil synergism for anaesthetic induction in patients. Anesth Analg 69: 213–217
Tverskoy M, Fleyshman G, Bradley EL, Kissin I (1988) Midzolam-thiopental anesthetic interaction in patients. Anesth Analg 67: 342–345
Tverskoy M, Ben-Shlomo I, Ezry J, Finger J, Fleyshman G (1989) Midazolam acts synergistically with methohexitone for induction of anaesthesia. Br J Anaesth 63: 109–122
Tverskoy M, Fleyshman G, Ezry J, Bradley EL, Kissin I (1989)Midzolam-morphine sedative interaction in patients. Anesth Analg 68: 282–285
Tucker MR, Ochs MW, White PW (1986) Arterial blood gas levels after midazolam or diazepam administered with or without fentanyl as an intravenous sedative for outpatient surgical procedures. J Oral Maxillofac Surg 44:688– 692
Dolan EA, Murray WJ, Immediata AR, Gleason N (1988) Comparison of nalbuphine and fentanyl in combination with diazepam for outpatient oral surgery. J Oral Maxillofac Surg 46: 471–473
Sury MR J, Cole PV (1988) Nalbuphine combined with midazolam for outpatient sedation. An assessment in fibreoptic bronchoscopy patients. Anaesthesia 43:285– 288
Romagnoli A, Keats AS (1980) Ceiling effect for respiratory depression by nalbuphine. Clin Pharmacol Ther 27: 478–485
Elwood RJ, Hildebrand PJ, Dundee JW, Collier PS (1983) Ranitidine influences the uptake of oral midazolam. Br J Clin Pharmacol 15: 743–745
Fee JPH, Collier PS, Howard PJ, Dundee JW (1987) Cimetidine and ranitidine increase midazolam bioavailability. Clin Pharmacol Ther 41: 80–84
Knüchel M, Ochs HR, Verbrug-Ochs B, Labedzki L, Greenblatt DJ (1987) Interaktion von Ranitidin und Cimetidin mit Midazolam bei intravenöser und oraler Gabe. Med Welt 38: 244–248
Buckley MMT, Brogden RM (1990) Ketorolac. A review of the pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 39:86– 109
Amrein R, Leishman B, Bentzinger C, Roncari G (1987) Flumazenil in benzodiazepine antagonism. Actions and clinical use in intoxication and anaesthesiology. Medical Toxicology 2: 411–429
Klotz U, Kanto J (1988) Pharmacokinetics and clinical use of flumazenil. Clin Pharmacokinet 14: 1–12
Whitwam JG (1988) Flumazenil: a benzodiazepine antagonist. Br Med J 297: 999–1000
Fisher GC, Hutton P (1989) Cardiovascular responses to flumazenil-induced arousal after arterial surgery. Anaesthesia 44: 104–106
Wolff J, Carl P, Clausen TG, Mikkelsen BO (1986) Rol5-1788 for postoperative recovery. A randomised clinical trial in patients undergoing minor surgical procedures under midazolam anaesthesia. Anaesthesia 41: 1001–1006
Alon E, Baitella L, Hossli G (1987) Double-blind study of the reversal of midazolam- supplemented general anaesthesia with Rol5-1788. Br J Anaesth 59: 455–458
Data on file. F Hoffmann-La Roche Ltd., Basle, Switzerland
Ricou R, Forster A, Bruckner A, Chastonay P, Gemperle M (1986) Clinical evaluation of a specific benzodiazepine antagonist (Ro 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation. Br J Anaesth 58: 1005–1011
Sage DJ, Chase A, Boas RA (1987) Reversal of midazolam sedation with Anexate. Br J Anaesth 59: 459–464
Jensen S, Knudsen L, Kirkegaard L (1988) Flumazenil used in the antagonizing of diazepam and midazolam sedation in outpatients undergoing gastroscopy. Eur J Anaesthesiol Suppl 2: 161–166
Rodrigo C, Rosenquist JB (1987) The effect of Rol5-1788 ( Anexate) on conscious sedation produced with midazolam. Anaesth Intensive Care 15: 185–192
Holloway AM, Logan DA (1988) The use of flumazenil to reverse diazepam sedation after endoscopy. Eur J Anaesthesiol Suppl 2: 191–198
Kirkegaard I, Knudsen L, Jensen S, Kruse A (1986) Benzodiazepine antagonist Ro15-1788. Antagonism of diazepam sedation in outpatients undergoing gastroscopy. Anaesthesia 41: 1184–1188
Andrews PJD, Wright DJ, Lamont MC (1988) Flumazenil in the outpatient. A study following midazolam as sedation for upper gastrointestinal endoscopy of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 43: 324–331
Nutt D, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Arch Gen Psychiatry 47: 917–925
Louis M, Forster A, Suter PM, Gemperle M (1984) Clinical and haemodynamic effects of a specific benzodiazepine antagonist (Ro 15–1788) after open heart surgery. Anesthesiology 513A
Editorial (1988) Midazolam — is antagonism justified? Lancet 1: 140–142
Ashton H (1984) Benzodiazepine withdrawal: an unfinished story. Br Med J 288: 1135–1140
Cumin R, Bonetti EP, Scherschlicht R, Haefely WE (1982) Use of the specific benzodiazepine antagonist Rol5~1788 in studies of physiological dependence on benzodiazepine. Experientia 38: 833–834
Savic I, Widen L, Stone-Elander S (1991) Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337: 133–137
Bell GD, Reeve PA, Moshiri M et al (1987) Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper-gastrointestinal endoscopy. Br J Clin Pharmacol 23: 703–708
Mora CT, Torjman M, White PF (1989) Effects of diazepam and flumazenil on sedation and hypoxic ventilatory response. Anesth Analg 68: 473–478
Power SJ, Chakrabarti MK, Whitwam JG (1984) Response to carbon dioxide after oral midazolam and pentobarbitone. Anaesthesia 39: 1183–1187
Deham A, Ward DS (1991) Effect of i.v. midazolam on the ventilatory response to substained hypoxia in man. Br J Anaesth 66: 454–457
Forster A, Fardaz JP, Suter PM, Gemperle M (1980) Respiratory depression by midazolam and diazepam. Anesthesiology 53: 494–497
Power SJ, Morgan M, Chakrabarti MK (1983) Carbon dioxide response curves following midazolam and diazepam. Br J Anaesth 55: 837–841
Dundee JW, Wyant GM (1974) Intravenous anaesthesia. Edinburgh: Churchill Livingstone
Al-Khudhairi D, Askitopoulou H, Whitwam JG (1982) Acute tolerance to the central respiratory effects of midazolam in the dog. Br J Anaesth 54: 953–958
Weinbrum A, Geller E (1990) The respiratory effects of reversing midazolam sedation with flumazenil in the presence or absence of narcotics. Acta Anaesthesiol Scand Suppl 92 34: 65–69
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Whitwam, J. (1991). Drugs for Sedation. In: McCloy, R., Davies, A.P. (eds) Quality Control in Endoscopy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77138-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-77138-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77140-8
Online ISBN: 978-3-642-77138-5
eBook Packages: Springer Book Archive